一个预先安排的独立安全监测委员会（SMC）建议使用opaganib治疗新冠肺炎的美国2期研究按原方案进行；该项研究的患者招募已完成超过50%，预计招募工作将在未来数周完成
—
与美国2期研究同时进行的opaganib治疗新冠肺炎全球2/3期研究在意大利获得批准；这项研究已经在英国、俄罗斯和墨西哥获得批准，并正在其他一些国家接受审核
—
opaganib全球2/3期研究已完成首批患者招募，总共计划在40处临床研究中心招募270名重症新冠肺炎住院患者
—
最早可能于2020年第四季度提交全球紧急用药申请
Before you continue, please confirm the following:
Professional advisers only
I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.
Important Notice for Investors:
The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.
No Investment Advice:
The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.
High Risks:
Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.
Sole Responsibility:
The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.
No Guarantees:
Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.
Regional Restrictions:
The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.
Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.